Gabriel India Limited

GABRIEL.BO·BSE·Consumer Cyclical
Compare
1,414.00−68.75 (−4.64%)today
As of Oct 21, 2:37 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1,482.75
Open1,486.00
Day range1,403.401,493.10
52-week range435.601,493.10
Off day high−5.30%
Off 52-week high−5.30%
Volume29.25K
Avg. volume (3M)43.60K
Market cap203.11B
EPS (TTM)-1,227.02
Forward P/E46.32
P/E ratio (TTM)—
Dividend yield0.50% (4.85)
Beta (5Y)0.50
Shares outstanding143.64M
Short interest—
Earnings dateAug 12, 2025 (est.)
Analyst target1,212.33
Profit margin5.52%

Against its peers

Compare in full ›
GABRIEL.BO ENDURANCE.NS ZFCVINDIA.NS ASKAUTOLTD.NS TALBROAUTO.NS 7296.T
Market cap 203.11B 328.55B 237.88B 108.60B 21.03B 198.09B
P/E (TTM) — 33.9 2.2 34.3 18.8 10.2
Forward P/E 46.3 23.0 31.4 24.7 — 15.1
Price/book 15.9 4.8 6.4 8.3 2.8 1.0
Dividend yield 0.50% 0.49% 0.19% 0.33% 0.21% 4.29%
1-year change +96.73% −19.90% −1.83% +11.08% +16.71% +35.27%
Today −4.64% −1.40% −2.36% −2.79% −3.50% −0.60%

The closest companies by business and industry (Auto Parts). Prices may be delayed up to 20 min.

Kalkine India·Positive

Trade Spotlight: Gabriel India, Dr Reddy's Among Counters Watched

The Counters in Focus The spotlight gathered five names from across the market. Gabriel India (NSE: GABRIEL), an auto-components counter, and Dr Reddy's Laboratories (NSE: DRREDDY), a major pharmaceutical name, headed the list. They were…

From articles in the 4Search news index.

In the news

11mentions in 30 days
11with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.